Maria Sklodowska-Curie National Research Institute of Oncology
🇵🇱Poland
- Country
- 🇵🇱Poland
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.pib-nio.pl/
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
Phase 2
- Conditions
- FibrosarcomaSarcomaLiposarcoma, DedifferentiatedLeiomyosarcomaMalignant Peripheral Nerve Sheath TumorsSynovial SarcomaUndifferentiated Pleomorphic SarcomaAlveolar Soft Part SarcomaClear Cell SarcomaMyxoid Liposarcoma
- Interventions
- Radiation: Hypofractionated radiotherapyOther: Hyperthermia
- First Posted Date
- 2019-06-18
- Last Posted Date
- 2021-02-01
- Target Recruit Count
- 30
- Registration Number
- NCT03989596
- Locations
- 🇵🇱
Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Mazovian, Poland
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)
Phase 2
- Conditions
- Myxoid Liposarcoma
- Interventions
- Radiation: Hypofractionated radiotherapy
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2019-06-17
- Target Recruit Count
- 35
- Registration Number
- NCT03816475
- Locations
- 🇵🇱
Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Mazovian, Poland
Participation in Competing Strategies for Colorectal Cancer Screening - a Randomized Health Services Study Within the National Screening Program in Poland
Not Applicable
- Conditions
- Colorectal Cancer
- Interventions
- Other: Offering an alternative colorectal cancer screening methodOther: Offering a choice for colorectal cancer screening
- First Posted Date
- 2018-12-31
- Last Posted Date
- 2018-12-31
- Target Recruit Count
- 12298
- Registration Number
- NCT03790475
- Locations
- 🇵🇱
Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
Phase 2
- Conditions
- FibrosarcomaLiposarcomaMyosarcomaPleomorphic LiposarcomaSarcomaMyxoid LiposarcomaUndifferentiated Pleomorphic SarcomaMalignant Triton TumorLeiomyosarcomaHistiocytic Sarcoma
- Interventions
- Drug: Sequential chemotherapy - 3 courses of AIRadiation: Hypofractionated radiotherapy
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2021-01-22
- Target Recruit Count
- 46
- Registration Number
- NCT03651375
- Locations
- 🇵🇱
Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Mazovian, Poland
Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
Completed
- Conditions
- Thyroid NeoplasmThyroid NoduleThyroid Cancer
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2021-09-05
- Target Recruit Count
- 599
- Registration Number
- NCT03392402
- Locations
- 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Gliwice, Poland
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Phase 3
- Conditions
- Hodgkin's LymphomaNon-Hodgkin's Lymphoma
- Interventions
- Drug: Cytosine arabinoside with G-CSF (filgrastim)
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2016-03-30
- Target Recruit Count
- 90
- Registration Number
- NCT02722733
- Locations
- 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.
Not Applicable
Completed
- Conditions
- Multiple MyelomaLymphomasLeukemias
- Interventions
- Procedure: Cryopreservation of HSCs using 10% DMSO concentrationProcedure: Cryopreservation of HSCs using 5% DMSO concentrationProcedure: Cryopreservation of HSCs using 7,5% DMSO concentration
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2017-01-18
- Target Recruit Count
- 150
- Registration Number
- NCT02452099
- Locations
- 🇵🇱
MSC Memorial CAncer Center and Institute of Oncology, Gliwice, Poland
The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers
Not Applicable
Completed
- Conditions
- Esophageal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck
- Interventions
- Procedure: NBI endoscopyProcedure: Lugol chromoendoscopy
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2018-04-13
- Target Recruit Count
- 294
- Registration Number
- NCT02435602
- Locations
- 🇵🇱
Maria Sklodowska-curie Memorial Cancer Center, Institiute of Oncology, Warsaw, Poland
An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
Phase 2
- Conditions
- Parkinson Disease
- Interventions
- Radiation: Radiosurgical thalamotomyDrug: CyberKnife
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2015-04-02
- Target Recruit Count
- 27
- Registration Number
- NCT02406105
- Locations
- 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Wybrzeze AK 15, Poland
CyberKnife Based Hypofractionated Radiotherapy for Vertebral Hemangiomas
Phase 3
- Conditions
- Hemangioma of Vertebral Column
- Interventions
- Radiation: Cybernetic microradiosurgeryRadiation: Conventional radiotherapy
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2015-01-06
- Target Recruit Count
- 80
- Registration Number
- NCT02332408
- Locations
- 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Wybrzeze AK 15, Poland
© Copyright 2025. All Rights Reserved by MedPath